BARCLAYS PLC - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.19 and the average weighting 0.4%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$1,529,000
-32.7%
122,961
-25.9%
0.00%0.0%
Q3 2016$2,272,000
+174.4%
165,941
+48.2%
0.00%0.0%
Q2 2016$828,000
+29.8%
112,005
+5.5%
0.00%
+100.0%
Q1 2016$638,000
-74.6%
106,122
-74.6%
0.00%
-66.7%
Q4 2015$2,507,000
+80.0%
417,855
+50.1%
0.00%
+200.0%
Q3 2015$1,393,000
-30.1%
278,432
+11.7%
0.00%
-50.0%
Q2 2015$1,994,000
+10.7%
249,333
+10.7%
0.00%0.0%
Q1 2015$1,802,000
-69.2%
225,287
-76.9%
0.00%
-60.0%
Q4 2014$5,845,000
+43.1%
974,163
+19.3%
0.01%
+25.0%
Q3 2014$4,085,000
-58.0%
816,602
-49.6%
0.00%
-63.6%
Q2 2014$9,715,000
-55.7%
1,619,040
-40.9%
0.01%
-54.2%
Q1 2014$21,925,000
+43.0%
2,740,650
+7.2%
0.02%
+50.0%
Q4 2013$15,333,000
+90.5%
2,555,481
+471.5%
0.02%
+77.8%
Q3 2013$8,050,000
+98.6%
447,167
+93.0%
0.01%
+80.0%
Q2 2013$4,054,000231,7150.01%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$82,111,00018.09%
Consonance Capital Management LP 5,575,742$35,629,0005.39%
Opaleye Management Inc. 1,250,000$7,988,0004.98%
Tamarack Advisers, LP 1,600,000$10,224,0003.58%
Camber Capital Management LP 5,405,235$34,539,0002.02%
IRONWOOD INVESTMENT MANAGEMENT LLC 324,636$2,074,0001.36%
Palo Alto Investors LP 2,248,317$14,367,0001.12%
1492 Capital Management LLC 202,500$1,294,0001.09%
Geduld E E 120,100$767,0001.05%
JS Capital Management LLC 868,700$5,551,0001.00%
View complete list of ARIAD PHARMACEUTICALS INC shareholders